<font color="blue">Safety_3</font> <font color="blue">and_1</font> <font color="blue">preliminary_3</font> <font color="blue">immunogenicity_4</font> <font color="blue">of_1</font> <font color="blue">Cuban_2</font> <font color="blue">pneumococcal_2</font> <font color="blue">conjugate_2</font> <font color="blue">vaccine_2</font> <font color="blue">candidate_1</font> in <font color="blue">healthy_1</font> <font color="blue">children_1</font> <font color="blue">:_1</font> a randomized phase I clinical trial . 
<br>
<br> A <font color="blue">new_1</font> <font color="blue">heptavalent_1</font> <font color="blue">conjugate_1</font> <font color="blue">vaccine_1</font> <font color="blue">(_1</font> <font color="blue">PCV7-TT_1</font> <font color="blue">)_1</font> <font color="blue">is_1</font> <font color="blue">under_1</font> <font color="blue">development_1</font> in <font color="blue">Cuba_1</font> <font color="blue">._1</font> <font color="blue">PCV7-TT_1</font> <font color="blue">contains_1</font> <font color="blue">2_1</font> <font color="blue">μg_1</font> <font color="blue">of_1</font> <font color="blue">serotypes_1</font> <font color="blue">1_1</font> <font color="blue">,_1</font> <font color="blue">5_1</font> <font color="blue">,_1</font> <font color="blue">14_1</font> <font color="blue">,_1</font> <font color="blue">18C_1</font> <font color="blue">,_1</font> <font color="blue">19F_1</font> <font color="blue">,_1</font> <font color="blue">23F_1</font> <font color="blue">and_1</font> <font color="blue">4_1</font> <font color="blue">μg_1</font> <font color="blue">of_1</font> <font color="blue">6B_1</font> <font color="blue">,_1</font> <font color="blue">each_1</font> <font color="blue">one_1</font> <font color="blue">conjugated_1</font> <font color="blue">to_1</font> <font color="blue">tetanus_1</font> <font color="blue">toxoid_1</font> <font color="blue">(_1</font> <font color="blue">TT_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> This <font color="blue">vaccine_1</font> <font color="blue">was_1</font> <font color="blue">designed_1</font> <font color="blue">with_1</font> <font color="blue">the_1</font> <font color="blue">serotypes_1</font> that <font color="blue">cause_1</font> <font color="blue">most_1</font> <font color="blue">invasive_1</font> <font color="blue">pneumococcal_1</font> <font color="blue">diseases_1</font> <font color="blue">(_1</font> <font color="blue">IPD_1</font> <font color="blue">)_1</font> <font color="blue">worldwide_1</font> <font color="blue">._1</font> In the <font color="blue">present_1</font> <font color="blue">study_1</font> <font color="blue">,_1</font> we <font color="blue">investigated_1</font> <font color="blue">the_1</font> <font color="blue">safety_3</font> <font color="blue">and_2</font> <font color="blue">explored_2</font> <font color="blue">the_1</font> <font color="blue">immunogenicity_3</font> <font color="blue">of_1</font> <font color="blue">PCV7-TT_1</font> during a controlled , randomized and double blind clinical trial <font color="blue">phase_1</font> <font color="blue">I_1</font> <font color="blue">in_1</font> <font color="blue">4_1</font> <font color="blue">-_1</font> <font color="blue">5-year_1</font> <font color="blue">-_1</font> <font color="blue">old_1</font> <font color="blue">children_1</font> <font color="blue">._1</font> <font color="blue">PCV7-TT_1</font> was <font color="blue">well_2</font> <font color="blue">tolerated_5</font> and as <font color="blue">safe_4</font> as <font color="blue">Synflorix_1</font> <font color="blue">used_1</font> <font color="blue">as_1</font> <font color="blue">control_1</font> <font color="blue">vaccine_1</font> <font color="blue">._1</font> <font color="blue">Following_1</font> <font color="blue">a_1</font> <font color="blue">single_1</font> <font color="blue">-_1</font> <font color="blue">dose_1</font> <font color="blue">vaccination_1</font> <font color="blue">,_1</font> all <font color="blue">individual_1</font> <font color="blue">serotypes_1</font> <font color="blue">included_1</font> <font color="blue">in_1</font> <font color="blue">PCV7-TT_1</font> induced <font color="blue">statistically_2</font> <font color="blue">significant_2</font> <font color="blue">increase_4</font> <font color="blue">of_3</font> <font color="blue">IgG_6</font> <font color="blue">GMC_6</font> <font color="blue">and_6</font> <font color="blue">OPA_6</font> <font color="blue">GMT_6</font> <font color="blue">._6</font> These are <font color="blue">the_1</font> <font color="blue">first_1</font> <font color="blue">clinical_2</font> <font color="blue">results_2</font> <font color="blue">of_1</font> <font color="blue">PCV7-TT_1</font> in children and <font color="blue">they_1</font> <font color="blue">pave_1</font> <font color="blue">the_1</font> <font color="blue">way_1</font> <font color="blue">toward_1</font> <font color="blue">next_1</font> <font color="blue">clinical_1</font> <font color="blue">trials_1</font> <font color="blue">in_1</font> <font color="blue">children_1</font> and <font color="blue">infants_1</font> <font color="blue">._1</font> <font color="blue">This_1</font> <font color="blue">clinical_1</font> <font color="blue">trial_1</font> <font color="blue">was_1</font> <font color="blue">published_1</font> in the <font color="blue">Cuban_1</font> <font color="blue">Public_1</font> <font color="blue">Register_1</font> <font color="blue">of_1</font> <font color="blue">Clinical_1</font> <font color="blue">Trials_1</font> with <font color="blue">code_1</font> <font color="blue">RPCEC00000173_1</font> <font color="blue">._1</font>